The prevalent KRAS exon 2 c.35 G>A mutation in metastatic colorectal cancer patients: A biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens?
| Image |  |
|---|---|
| Description | scientific article published on 16 October 2014 |
| Author/s |
author: Alessandra Tessitore Katia Cannita Corrado Ficorella Enrico Ricevuto |
| Publication date | October 16, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |